Healthcare Services

Omics Lab Services Market Revenue Growth Expected to Reach $224.13 Billion by 2030 with 15.4% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Omics Lab Services Market By The End Of 2030?

The omics lab services market size has experienced rapid expansion in recent years. It is projected to increase from $109.47 billion in 2025 to $126.6 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. The market’s historical growth can be attributed to the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to experience swift expansion in the coming years. Its valuation is projected to reach $224.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This projected growth during the forecast timeframe is attributable to factors such as the expanding embrace of personalized medicine research, heightened investments in systems biology, the proliferation of AI-enabled bioinformatics tools, an escalating need for comprehensive omics solutions, and a sharpened emphasis on drug discovery propelled by data. Key developments expected within this period encompass a surging demand for integrated multi-omics analysis, a rise in the utilization of contract research services, the broadened scope of bioinformatics-driven data interpretation, an increased deployment of high-throughput analytical platforms, and a strengthened commitment to supporting translational research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Omics Lab Services Market?

An increase in genetic disease cases is anticipated to drive the expansion of the omics lab services market in the future. These conditions stem from DNA abnormalities or mutations, which can be passed down or emerge spontaneously. The growing number of genetic disease cases is attributed to significant improvements in diagnostic technologies, such as next-generation sequencing and other genomic instruments, which have enhanced the capacity to identify numerous genetic disorders that were previously undetected or incorrectly categorized. Omics lab services aid in managing genetic diseases by scrutinizing intricate biological data to pinpoint mutations and molecular alterations, facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, the Cystic Fibrosis Trust, a UK charity assisting those with cystic fibrosis, reported in October 2024 that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, showing a 1.5% annual rise in patient registrations. Consequently, the increased occurrence of genetic diseases is fueling the expansion of the omics lab services market.

Which Segment Classifications Shape The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Industry Trends Are Redefining The Omics Lab Services Market?

Leading companies within the omics lab services market are prioritizing the development of innovative solutions, such as high-throughput genomics, to accelerate both biomedical research and precision medicine efforts. High-throughput genomics involves leveraging advanced technologies to rapidly sequence and analyze significant volumes of DNA or RNA, thereby enabling efficient large-scale genetic studies. For example, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, introduced the Center for Spatial Multi-Omics (COSMO). This center offers high-resolution whole-transcriptome data by using sequencing-based Visium HD in conjunction with histological staining, and also provides tissue processing services like Tissue Microarray (TMA) construction for economical, multiplexed sample analysis. Its adaptable platforms, further enhanced by machine learning-driven cell segmentation, allow for detailed visualization and mapping of molecular data within intact tissues, supporting advancements in precision medicine and disease research.

Which Companies Are Expanding Their Footprint In The Omics Lab Services Market?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Read the full omics lab services market report here:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Regions Are Projected To Dominate The Omics Lab Services Market In The Coming Years?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omics Lab Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Global Market Report

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Global Market Report

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Global Market Report

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795